| Dr Hilary C Nosker, DPM | |
|
117 N Braddock St, Suite 150, Winchester, VA 22601-3969 | |
| (540) 662-4572 | |
| Not Available |
| Full Name | Dr Hilary C Nosker |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 13 Years |
| Location | 117 N Braddock St, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326336256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 0103301119 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winchester Medical Center | Winchester, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Winchester Foot And Ankle Associates Pllc | 6305813312 | 3 |
News Archive
Aragen Bioscience, Inc., today announced it is a subcontractor on a National Institute of Allergy and Infectious Diseases contract for the preclinical development of monoclonal antibodies for the prevention and treatment of infectious diseases.
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A new USC study published in the journal Pediatrics finds a heightened risk of death from medical causes for infants with histories of reported maltreatment, suggesting a need for ongoing care coordination between the child protection system and pediatric health providers.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
› Verified 4 days ago
| Provider Name | Winchester Foot & Ankle Associates Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144250853 PECOS PAC ID: 6305813312 Enrollment ID: O20050804001225 |
News Archive
Aragen Bioscience, Inc., today announced it is a subcontractor on a National Institute of Allergy and Infectious Diseases contract for the preclinical development of monoclonal antibodies for the prevention and treatment of infectious diseases.
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A new USC study published in the journal Pediatrics finds a heightened risk of death from medical causes for infants with histories of reported maltreatment, suggesting a need for ongoing care coordination between the child protection system and pediatric health providers.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hilary C Nosker, DPM 117 N Braddock St, Suite 150, Winchester, VA 22601-3969 Ph: (540) 662-4572 | Dr Hilary C Nosker, DPM 117 N Braddock St, Suite 150, Winchester, VA 22601-3969 Ph: (540) 662-4572 |
News Archive
Aragen Bioscience, Inc., today announced it is a subcontractor on a National Institute of Allergy and Infectious Diseases contract for the preclinical development of monoclonal antibodies for the prevention and treatment of infectious diseases.
The vast majority of already published and relevant clinical trials of a given drug, device or procedure are routinely ignored by scientists conducting new research on the same topic, a new Johns Hopkins study suggests.
A new USC study published in the journal Pediatrics finds a heightened risk of death from medical causes for infants with histories of reported maltreatment, suggesting a need for ongoing care coordination between the child protection system and pediatric health providers.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
› Verified 4 days ago
Dr. Paul Alexander Kushlak, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 117 N Braddock St, Suite 150, Winchester, VA 22601 Phone: 540-662-4572 Fax: 540-722-9519 | |
Winchester Foot & Ankle Associates Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 117 N Braddock St, Suite 150, Winchester, VA 22601 Phone: 540-662-4572 Fax: 540-722-9519 | |
Foot Care Center Plc Podiatrist Medicare: Medicare Enrolled Practice Location: 621 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-667-0130 Fax: 540-667-3893 | |
Dr. Alex Gorenshtein, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 912 S. Pleasant Valley Road, Winchester, VA 22601 Phone: 540-662-6822 Fax: 540-662-6903 | |
Foot & Ankle Center Podiatrist Medicare: Medicare Enrolled Practice Location: 912 S Pleasant Valley Rd, Winchester, VA 22601 Phone: 540-662-6822 Fax: 540-662-1903 | |
Dr. Andrew Lloyd Vincent, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 650 Cedar Creek Grade Ste 108, Winchester, VA 22601 Phone: 540-667-3338 Fax: 540-667-1589 | |
James E Dodd Ii, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 117 N Braddock St, Suite 150, Winchester, VA 22601 Phone: 540-662-4572 Fax: 540-722-9519 |